Do Higher Radiation Doses with Concurrent Chemotherapy in the Definitive Treatment of Esophageal Cancer Improve Outcomes? A Meta-Analysis and Systematic Review
Conclusion: Under the premise of controlling the rate of toxicities, doses of ≥ 60 Gy in CT-based dCCRT of ESCC patients might improve locoregional control and ultimate survival compared to the standard-dose dCCRT. While our review supports a dose-escalation approach in these patients, multiple ongoing randomized trial initial and final reports are awaited to evaluate the effectiveness of this strategy.
Source: Journal of Cancer - Category: Cancer & Oncology Authors: Linlin Xiao, Brian G. Czito, Qingsong Pang, Zhouguang Hui, Shaowu Jing, Baoen Shan, Jun Wang Tags: Research Paper Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Computers | Esophagus Cancer | Proton Therapy | Skin Cancer | Squamous Cell Carcinoma | Study | Toxicology